Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780026 · ClinicalTrials.gov registry record · Phase 4
Intraoperative Glucose Control in Liver Transplant
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00780026 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 100 participants.
The verdict
NCT00780026, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of the proposed study is to evaluate the effectiveness of intraoperative, strict glycemic control to improve survival and infection rates following liver transplantation in a randomized, prospective trial.Primary objective: To determine if strict intraoperative blood glucose control, when compared to standard intraoperative glycemic control, improves 1-year recipient survival and decreases surgical complications, including infections, following liver transplantation.
Interventions
- DRUG insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780026
The ClinicalTrials.gov registry entry for NCT00780026 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which insulin is the first listed.
NCT00780026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00780026 about?
NCT00780026 is a clinical study titled "Intraoperative Glucose Control in Liver Transplant". The goal of the proposed study is to evaluate the effectiveness of intraoperative, strict glycemic control to improve survival and infection rates following liver transplantation in a randomized, prospective trial.Primary objective: To determine if strict intraoperative blood glucose control, when c...
What is the current status of trial NCT00780026?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2008-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00780026?
The interventions under investigation include: insulin (DRUG).
Who is sponsoring clinical trial NCT00780026?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.